MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study by Hong, David S, Prof, Hui, David, MD, Bruera, Eduardo, Prof, Janku, Filip, MD, Naing, Aung, MD, Falchook, Gerald S, MD, Piha-Paul, Sarina, MD, Wheler, Jennifer J, MD, Fu, Siqing, MD, Tsimberidou, Apostolia M, MD, Stecher, Michael, MD, Mohanty, Prasant, MBBS, Simard, John, BSc, Kurzrock, Razelle, Prof

Get full text

Azacitidine enhances sensitivity of platinum-resistant ovarian cancer cells to carboplatin through induction of apoptosis by Li, Yanfang, MD, Hu, Wei, MD, PhD, Shen, De-Yu, MS, Kavanagh, John J., MD, Fu, Siqing, MD, PhD

Get full text

Nuclear cyclin B1 is overexpressed in low-malignant-potential ovarian tumors but not in epithelial ovarian cancer by Zheng, Hong, MD, PhD, Hu, Wei, MD, PhD, Deavers, Michael T., MD, Shen, De-Yu, MS, Fu, Siqing, MD, PhD, Li, Yan-Fang, MD, Kavanagh, John J., MD

Get full text